Status: Not yet recruiting
Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Adenocarcinoma of Gastric/Esophagogastric Junction
This study, a single-center, open, single-dose clinical study, was designed to evaluate the safety and efficacy of IM96 CAR-T cells in treating patients with advanced adenocarcinoma of gastric/esophagogastric junction
Participants needed: 18
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Beijing Immunochina Medical Science & Technology Co., Ltd.Updated: Feb 13, 2026Locations: 1
Eligibility criteria
The age is 18 to 75 years (including boundary values) and the gender is not limi... [+13]
Presence of brain metastases; [+30]